A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease

Faustino TorricoJoaquím GascónLourdes OrtizJimy PintoGimena RojasAlejandro PalaciosFabiana BarreiraBethania BlumAlejandro G. SchijmanMichel Vaillant2026-03-222026-03-22202210.1093/cid/ciac579https://doi.org/10.1093/cid/ciac579https://andeanlibrary.org/handle/123456789/43667Citaciones: 51NCT02498782.enMedicinePlaceboIndeterminateMulticenter trialChagas diseaseRandomized controlled trialMulticenter studyInternal medicineIntensive care medicineA Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Diseasearticle